CP17736969424331807 — Ipilimumab 200 Mg/40ml IV Soln
Cite this view
HANK Price Transparency. (n.d.). Ipilimumab 200 Mg/40ml Iv Soln (CDM CP17736969424331807) negotiated rates. PPMan price-transparency data, derived from CMS-required hospital MRFs. Retrieved , from http://ppman.hank.ai/transparency/code/CP17736969424331807?code_type=CDM
“Ipilimumab 200 Mg/40ml Iv Soln (CDM CP17736969424331807) negotiated rates.” HANK Price Transparency, http://ppman.hank.ai/transparency/code/CP17736969424331807?code_type=CDM. Accessed .
“Ipilimumab 200 Mg/40ml Iv Soln (CDM CP17736969424331807) negotiated rates,” HANK Price Transparency, accessed , http://ppman.hank.ai/transparency/code/CP17736969424331807?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital machine-readable files (45 CFR 180). See methodology.
Usually $25,452–$35,022 (25th–75th percentile) across 1 hospital · 3 payers.
“Negotiated” is the hospital’s negotiated facility rate for this CDM CP17736969424331807 — the consumer-grade median across the country. It covers the facility charge only; the surgeon’s and anesthesiologist’s fees are billed separately.
Per-month price trends are temporarily unavailable while we rebuild them on quality-filtered rates. The medians, percentiles, and per-hospital rates on this page are the quality-filtered figures.
Hospital rates (per row)
Showing consumer-grade rates only. Flagged / outlier filings (excluded from the medians above) are hidden — tick “Show flagged / outlier rates” to include them.
| Hospital | Payer | Plan | Negotiated rate | Gross | Cash | Observed | Source |
|---|---|---|---|---|---|---|---|
| JAMESTOWN REGIONAL MEDICAL CENTER Both | NextBlue North Dakota | Medicare Advantage | $22,064.00 | $41,202.00 | $32,962.00 | 2026-05-22 | MRF ↗ |
| JAMESTOWN REGIONAL MEDICAL CENTER Both | Aetna | Commercial | $28,841.00 | $41,202.00 | $32,962.00 | 2026-05-22 | MRF ↗ |
| JAMESTOWN REGIONAL MEDICAL CENTER Both | Blue Cross Blue Shield North Dakota | Commercial | $41,202.00 | $41,202.00 | $32,962.00 | 2026-05-22 | MRF ↗ |